Exam 4 Flashcards

1
Q

Glycogen storage diseases

(GSDs)

A

Autosomal recessive disorders

Type 0 - VII + XI

  • abnormally inherited glycogen metabolism in the liver or muscle
  • build up of glycogen in tissues
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Von Gierke

Type I GSD

A
  • Deficiency of Glucose-6-Phosphatase (G6Pase) (1a) or G6P transporter (1b)
  • Liver cannot release free glucose in hypoglycemia
  • Excess G6P funneled back into glycolysis
    • elevated lactate levels
    • excess glycogen formation
  • Doll-like appearance

Results In:

  • Enlarged Liver + Kidney due to back up of G6P
  • growth failure
  • Severe fasting hypoglycemia + lactic acidemia
  • hyperuricemia + hyperlipidemia

Key Feature to Remember:

Growth failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pompe

Type II GSD

A

worst of GSD

  • Deficiency of lysosomal α-glucosidase (acid maltase)
  • Infants have enlarged heart, liver, and tongue
    • heart has high E demand t.f. expansion of mito # to compensate = enlarged heart
  • adults have enlarged skeletal muscle
  • no neurological effect

Results in

  • Muscle hypotonia
  • cardiac failure + cardiomegaly
  • massive glycogen deposits in lysosomes

Treated with ERT

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Cori

Type III GSD

A

short branched molecules

  • Deficiency of debranching enzyme
  • Hypertrophic cardiomyopathy during childhood
  • Liver transaminases in GSD III are highest

Results In:

  • Fasting hypoglycemia
  • hepatomegaly
  • Hypertrophic cardiomyopathy
  • Glycogen has short branches

no treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Andersen Disease

GSD IV

A

long glycogen molecules due to synthesis defect

  • Defect in Branching Enzyme

Results In:

  • Hepatomegaly, hypertonia, muscle atrophy
  • Glycogen Deposits abnormally long
  • straight glucose polymers with little branching
  • Progressive liver cirrhosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

McArdle

GSD Type V

A
  • Defect Muscle Phosphorylase
  • no liver affect

Results in

  • Exercise-induced muscle pain, cramps, progressive weakness,
  • myoglobinuria
  • reduced lactate output
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Hers

Type VI GSD

A

Most common

  • Deficiency of liver phosphorylase
  • Relies on Gluconeogenesis
  • mild symptoms

Results in

  • early childhood hepatomegaly + growth retardation
  • Hypoglycemia

No treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Tarui Syndrome

Type VII GSD

A
  • defect in PFK-1
  • affects glycolysis
  • inability to break glycogen

results in

  • hemolytic anemia
  • Exercise-induced muscle pain, cramps, progressive weakness
  • myoglobinuria
  • kidney failure
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Franconi-Bickel Syndrome

Type XI GSD

A
  • defect in GLUT2 transporter
  • severe hepatomegaly

Results in

  • glycogen accumulation in liver + kidney
  • rickets
  • growth retardation
  • glucosuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

General treatments for GSD’s

A
  • Frequent feeding
  • Cornstarch
    • during long periods of fasting
  • High protein diet
    • provides amino acids for gluconeogenesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Lysosomal Storage Diseases

A

mostly monogenic autosomal recessive LSDs

2 X-lined LSDs

Defects in degradative enzymes leads to accumulation of macromolecules in lysosomes

significant impact on CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Enzyme replacement therapy

A

Treats symptoms but not underlying disease

Possible treatment when a patient has an enzyme deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Fabry disease

A

X-linked

Deficiency in alpha-galactosidase A

involved in globoside degradation

accumulation of globoside

  • red-purple skin rash
  • kidney + heart failure
  • burning pain in Lower EXTR

Treat using ERT – Fabrazyme (recombinant human alpha-galactosidase A)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Tay-Sachs disease

A

Deficiency in hexosaminidase A

involved in ganglioside degradation

accumulation of gangliosides (GM2)

  • upper and lower motor neuron deficits
  • visual difficulties
    • cherry red macula
  • increasing cognitive dysfunction
    • seizures

common in ashkenazi jews

death by age 5

no treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Sandhoff disease

A

Deficiency in both hexosaminidase A (αβ) & hexosaminidase B (β2) due to defect in β subunit

involved in globoside degradation

accumulation of globosides + gangliosides (GM2)

  • accelerated Tays-Sachs s/s

common in ashkenazi jews

death by age 3

no treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Niemann-Pick Disease

Type A + Type B

A

Deficiency in sphingomyelinase

accumulation of sphingomyelin in brain, spleen + liver

  • Enlarged liver + spleen (lipid-filled)
  • cognitive impairment
  • cherry red macula
  • early childhood death in Type A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Niemann-Pick Disease

Type C

A

a defect in lipid transport of cholesterol and gangliosides from the lysosome

defect in NPC1 transmembrane protein

Type C is more common than A & B combined

18
Q

Gaucher disease

A

Deficiency in glucocerebrosidase

Accumulation of glucocerebroside in phagocytes

  • most common LSD
  • enlarged liver + spleen
  • osteoporosis of long bones
  • cognitive impairment
  • Gaucher cells have a c”rumpled tissue paper” appearance
  • risk factor for Parkinson’s

treatment = ERT

19
Q

Glycosaminoglycan disorders

A

Mucopolysaccharidoses

Defects in degradation of heparan sulfate

Confirmed by presence of oligosaccharides in urine

20
Q

Hurlers Syndrome

A

deficiency in alpha-L-iduronidase

most severe MPS I

Defects in degradation of heparan sulfate

  • deposition in coronary arteries
    • acute ischemia
  • corneal clouding
  • developmental disabilities
  • dwarfism
  • abnormal fascial features
  • hearing loss

treatment = ERT or bone marrow transplant

21
Q

Hunter Syndrome

A

x-linked

deficiency in iduronate sulfate

varying severity

Defects in degradation of heparan sulfate

  • no corneal clouding
  • mild to severe physical deformity
  • mild to severe developmental delay
22
Q

Sanfilippo Syndrome

MPS III

A

severe developemental delay

Four Types

  • Type A
    • heparan sulfamidase deficiency
  • Type B
    • n-acetylglucosaminidase deficiency
  • Type C
    • glucosaminide-n-acetyltransferase deficiency
  • Type D
    • n-acetylglucosamine-6-phosphate deficiency
23
Q

Sly Syndrome

MPS IV

A

beta-glucuronidase deficiency

  • enlarged liver + spleen
  • skeletal deformity
  • short stature
  • corneal clouding
  • developmental delay
24
Q

disease vs disorder vs syndrome

A
  • disease is a pathophysiological response
    • etiology is known
  • disorder is a disruption to regular bodily structure and function
    • etiology is unknown
  • syndrome is a collection of signs and symptoms associated with health issue
25
Q

most clotting factors in the body are produced in…

A

the liver

26
Q

3 responses to injury

A
  1. vasoconstriction to reduce blood flow
  2. formation of a physical plug by clumping of platelets
  3. formation of an insoluble clot through aggregation of fibrin

p.s. clot is dissolved after repair is complete

27
Q

Role of Platelets

A

no nucleus

form mechanical plugs at sites of injury

platelet granules secrete

  • ADP (signaling/recruiter)
    • potent platelet recruiter + activator
    • unmasks GPII binding sites
    • present in damaged cells as undamaged cells secrete ADPase
  • TXA2
    • aids in vasoconstriction + platelet aggregation
  • 5-HT (serotonin)
    • aids in vasoconstriction
  • Calcium
    • increases affinity of GPII proteins for fibrinogen
    • stimulates the production of cell surface GPCR for factors like thrombin
28
Q

Four Phases of Hemostasis

A

the process of stopping leakage from damaged blood vessels

  1. vascular phase
    • damaged vessels spasm to reduce blood flow
    • localized vasoconstriction (VC)
      • release of TXA2 + 5-HT stimulate VC
  2. platelet phase
    • damaged vessels express vWF on surface
    • platelets bind to vWF w. GPIb/Ia Receptor
      • platelets release ADP + TXA2 when bound
    • GPIIb/IIIa R allows platelets to bind to each other
  3. coagulation phase
    • production of thrombin is the beginning of coagulation
    • platelet plug is reinforced by insoluble fibrin
      • crosslinks the platelets together into an aggregate mass
      • entraps + stabilizes loose platelet plug
  4. fibrinolysis
29
Q

Coagulation Cascade

A

extrinsic + intrinsic converge

prothrombin – thrombin by Factor X

thrombin converts fibrinogen into fibrin for clotting

30
Q

Factor I

A

fibrinogen – fibrin

31
Q

Factor II

A

prothrombin – thrombin – serine protease

32
Q

Factor III

A

tissue factor – receptor + cofactor

33
Q

Factor IV

A

Calcium – cofactor

34
Q

Factor V

A

proaccelerin – cofactor

35
Q

Factor VII

A

proconvertin – serine protease

36
Q

Factor VIII

A

Hemophilia A – cofactor

37
Q

Factor IX

A

Hemophilia B – serine protease

38
Q

Factor X, XI

A

serine protease

39
Q

Factor XIII

A

Ca dependent transglutaminase

fibrin stabilizing factor

40
Q

vWF

A

stabilizes Factor VIII

41
Q
A